HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

On antibiotic prophylaxis in cardiac surgery: a risk factor for wound infection.

Abstract
During a 30-month period, median sternotomy wound infections or endocarditis developed during the first 60 days postoperatively following 20 of 1,204 (1.7%) adult cardiac procedures at the University of Maryland Hospital. Fifty percent of the infected patients received perioperative clindamycin prophylaxis. A retrospective study was conducted in which the odds ratio estimate of the relative risk of sternotomy infection or endocarditis for patients receiving clindamycin prophylaxis compared with patients receiving cefamandole was found to be 17.0 (p less than .001) using population controls and 8.25 (p less than .001) using matched controls. Seventy-five percent of the organisms causing infections, principally Staphylococcus epidermidis, were resistant in vitro to clindamycin. Perioperative clindamycin administration was not fully effective in preventing wound infection following cardiac surgery at our hospital, thus providing indirect evidence for the efficacy of prophylaxis with cephalosporin-containing regimens. Trials of alternative antibiotics to clindamycin for prophylaxis in penicillin-allergic patients undergoing cardiac surgery are indicated.
AuthorsD E Lilienfeld, D Vlahov, J H Tenney, J S McLaughlin
JournalThe Annals of thoracic surgery (Ann Thorac Surg) Vol. 42 Issue 6 Pg. 670-4 (Dec 1986) ISSN: 0003-4975 [Print] Netherlands
PMID3789857 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Clindamycin
  • Kanamycin
  • Cefamandole
Topics
  • Adult
  • Anti-Bacterial Agents (therapeutic use)
  • Cardiac Surgical Procedures
  • Cefamandole (administration & dosage)
  • Clindamycin (administration & dosage)
  • Drug Evaluation
  • Drug Resistance, Microbial
  • Humans
  • Kanamycin (administration & dosage)
  • Premedication
  • Retrospective Studies
  • Risk
  • Surgical Wound Infection (epidemiology, microbiology, prevention & control)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: